Vikesh Singh, MD, MSc
Disclosures: Consulting Fee-Abbvie-Other_Role-Consultant|Contracted Research-Theraly-Principal_Investigator|Contracted Research-Orgenesis-Principal_Investigator|Contracted Research-Abbvie-Principal_Investigator|Consulting Fee-Envara-Other_Role-Medical Advisory Board Participant - 08/18/2021

Dr. Singh is currently an Associate Professor of Medicine in the Division of Gastroenterology at the Johns Hopkins Medical Institutions. He is the Director of Pancreatology where he oversees the Pancreatitis Center and the Total Pancreatectomy with Islet Autotransplantation Program. He is also the Director of Endoscopy at Johns Hopkins Hospital. He graduated with a B.S. in Applied Mathematics-Biology from Brown University (1995), an M.D. from Johns Hopkins University School of Medicine (2001) and an M.Sc. in epidemiology from the Harvard School of Public Health (2008). He completed his residency training in internal medicine at Johns Hopkins Hospital in 2004 followed by a fellowship in gastroenterology from Brigham and Women’s Hospital in 2008. He then completed a 2 year advanced endoscopy fellowship, with a focus in pancreaticobiliary endoscopy, at the Johns Hopkins Hospital in 2010. His research is focused on clinical pancreatology with specific interests in the prevention of post-ERCP pancreatitis, use of pancreatitis genetics in clinical practice, and abdominal pain due to both pancreatic and non-pancreatic conditions. He is a founding member of the Pancreatic Quantitative Sensory Testing (P-QST) Consortium which is an international group of 5 academic centers dedicated to developing P-QST as a pain phenotyping tool for patients with pain due to benign and malignant pancreatic diseases.​ He has over 250 publications encompassing original scientific studies, review articles, book chapters, and guidelines/consensus statements. He has current or prior grant funding from the NIH/NIDDK, Department of Defense, ASGE, Cystic Fibrosis Foundation, Theraly, Abbvie and Orgenesis. He is a member of the Board of Directors of the National Pancreas Foundation. He is also a member of the inaugural Medical Advisory Board for the Familial Chylomicronemia Syndrome (FCS) Foundation.